Lisa Elliott

Lisa Elliott is an accomplished professional in the fields of global pricing, health economics, and market access, currently serving as VP of Global Asset and Payer Strategy at LEO Pharma since April 2020. With extensive experience as a member of the Global Commercial Leadership Team, Lisa leads the GPHM department, overseeing strategic pricing, HEOR, and market access teams. Prior roles include senior management positions at ALK, Novo Nordisk, Boehringer Ingelheim, and Health Technology Analysts, which involved developing reimbursement strategies and managing global market access initiatives for multiple pharmaceutical products. Lisa holds a PhD in Immunology from UNSW and a Bachelor's degree in Medical Science with Honours from the University of Technology Sydney.